Total Utang marang Modal Notable Labs Inc. (NTBL)

This chart illustrates that the current market value of the total debt-to-equity ratio for Notable Labs, Ltd. (NTBL) on the GURU.Markets platform is 0.00. The business relies on AI-driven predictive diagnostic services, where centralized data processing ensures high profitability. The development of personalized treatment regimens for blood cancer is attracting major pharmaceutical partners; however, a narrow specialization in early-stage development makes the model sensitive to binary trial outcomes.

notablelabs.com (NTBL): Rasio Utang marang Ekuitas saka 21.02.2024 nganti 02.11.2024

Rincian metrik lan analitis perusahaan Notable Labs Corp (NTBL)

- rega saham lan konsensus proyeksi valuasi:
Rega saham Notable Labs|NTBL - Target konsensus
- rincian kapitalisasi pasar:
Kapitalisasi pasar Notable Labs|NTBL - Nilai Perusahaan
- indikator kapitalisasi buku:
Aset Bersih saben Siji Saham Notable Labs|NTBL - Kapitalisasi Akuntansi|Rasio Kapitalisasi Pasar marang Nilai Buku notablelabs.com|NTBL - Gunggung Aset Perusahaan
- rincian utang lan likuiditas:
Total Utang marang Modal Notable Labs, Ltd.|NTBL - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang ekuitas Notable Labs, Ltd.|NTBL - Kewajiban utang agregat|Utang marang nilai buku Notable Labs|NTBL - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Notable Labs|Indikator likuiditas cepet notablelabs.com
- data bathi resik lan rasio valuasi:
NTBL - Bathi resik
Pambiji fundamental perusahaan:Notable Labs

Analyzing leverage is critical for balancing asset quality and business valuation, as the total liabilities-to-equity ratio determines the company's degree of financial dependence on borrowed funds. In the case of Notable Labs, Ltd. (NTBL), where the commercialization of its oncology platform requires long-term investment, changes in the proportion of total debt to equity reflect either the risk of underfunding or an excessive debt load during periods of regulatory review.

Analisis pesaing Notable Labs, Ltd.

ONC (BeiGene) - Total Utang marang Modal|Rasio Total Utang marang Ekuitas Halozyme Therapeutics, Inc. (HALO)|Total Utang marang Modal RVMD|Total Utang marang Modal Ascentage Pharma Corp (AAPG)|Utang marang Ekuitas CG Oncology, Inc. CGON|URGN: Rasio Utang marang Ekuitas|Bicara Therapeutics - Total Utang marang Modal|Personalis Inc (PSNL) - Rasio Total Utang marang Ekuitas|ERAS: Total Utang marang Modal|Utang marang Modal Delcath Corp (DCTH)|Utang marang Ekuitas Y-mAbs Therapeutics|AURA: Rasio Kabeh Utang marang Dana Pribadi|Rasio Total Utang marang Ekuitas CADL (Candel Therapeutics)|ARAY (Accuray Inc) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal SLS (SELLAS Life Sciences Group)|ACTU - Rasio Total Utang marang Ekuitas|CTOR: Rasio Total Utang marang Ekuitas|HURA - Total Utang marang Modal|Protara Therapeutics, Inc. (TARA) - Utang marang Ekuitas|Fate Therapeutics Inc - Rasio Kabeh Utang marang Dana Pribadi|WHWK (Aadi Bioscience, Inc.) - Total Utang marang Modal|Utang marang Modal TScan TCRX|Utang marang Ekuitas Champions Oncology (CSBR)|xbiotech.com - Rasio Utang marang Ekuitas|Utang marang Ekuitas CEL-SCI CVM|OS Therapies Inc. (OSTX) - Utang marang Modal|RADX: Rasio Total Utang marang Ekuitas|Artiva Biotherapeutics, Inc. - Utang Agregat marang Modal|ANL: Total Utang marang Modal|verupharma.com (VERU) - Total Utang marang Modal|TPST (Tempest Therapeutics, Inc.) - Total Utang marang Modal|Utang marang Ekuitas XLO|Utang marang Ekuitas Renovaro Inc. (RENB)|Utang marang Ekuitas MURA (muraloncology.com)|Total Utang marang Modal KAPA (Kairos Pharma)|OnKure Therapeutics, Inc. (OKUR) - Utang marang Modal|GDTC: Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi CRIS (Curis, Inc.)|apollomicsinc.com (APLM) - Utang marang Ekuitas|THAR (Tharimmune Corporation) - Utang marang Ekuitas|ADVB (Advanced Biomed Inc.) - Total Utang marang Modal|Total Utang marang Modal genprex.com|Total Utang marang Modal CLDI|Utang marang Ekuitas SBFM (Sunshine Biopharma Inc.)|Utang marang Ekuitas Xenetic Biosciences, Inc. XBIO|Koefisien Total Utang marang Modal Salarius Pharma (SLRX)|PPBT: Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi AONC (American Oncology Network)|BeiGene (BGNE) - Utang marang Ekuitas|CKPT (Checkpoint Therapeutics Inc.) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas ELEV|ICAD (iCAD Corp) - Utang Agregat marang Modal|Total Utang marang Modal IKNA|viracta.com - Rasio Utang marang Ekuitas|MorphoSys - Rasio Total Utang marang Ekuitas|Koefisien Total Utang marang Modal NAYA Biosciences Inc (NAYA)|AAPGV - Utang marang Ekuitas